A Study Looking at a Drug to Treat Stage 4 Lung Cancer

What we are studying

The purpose of this research study is to see what effects (good and bad) the chemotherapy drug pemetrexed has on you and your condition. Pemetrexed has been approved by the US Food and Drug Administration (FDA) for patients with advanced lung cancer, but current cancer treatment guidelines limit chemotherapy use to patients who are ambulatory and capable of all self-care. Pemetrexed has shown anti-cancer benefit and been well-tolerated in these patients. Side effects can be minimized with folic acid, vitamin B12, and corticosteroids. In addition to these patients, we believe that pemetrexed can provide anti-cancer benefit and be well-tolerated in patients who are capable of only limited self-care.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Diagnosis of stage 4 non small cell lung cancer

What is involved

  • IV treatment with pemetrexed
  • Physical exams
  • Blood draws

Compensation

Parking will be validated for all study related visits.

Contact Information

Study Coordinator
Michele Harmon
Email
mharmon@wakehealth.edu
Phone
336-713-6925
Principal Investigator
Dr. Stefan Grant

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.